Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $17.3 million versus the consensus estimate of $14.34 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.